Ilya Yuffa's most recent trade in Lilly(Eli) & Co was a trade of 1,250 Common Stock done at an average price of $749.2 . Disclosure was reported to the exchange on May 14, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Sale of securities on an exchange or to another person at price $ 749.24 per share. | 14 May 2025 | 1,250 | 27,509 (0%) | 0% | 749.2 | 936,550 | Common Stock |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 868.92 per share. | 10 Feb 2025 | 7,123 | 28,759 (0%) | 0% | 868.9 | 6,189,335 | Common Stock |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2025 | 3,394 | 3,394 | - | - | Restricted Stock Unit | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 23,071 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2025 | 3,269 | 0 | - | - | Restricted Stock Unit | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 811.29 per share. | 01 Feb 2025 | 1,434 | 21,636 (0%) | 0% | 811.3 | 1,163,394 | Common Stock |
| Eli Lilly | Yuffa Ilya | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 737.26 per share. | 12 Feb 2024 | 4,790 | 19,802 (0%) | 0% | 737.3 | 3,531,475 | Common Stock |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 3,269 | 3,269 | - | - | Restricted Stock Unit | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,702 | 0 | - | - | Restricted Stock Unit | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 3,702 | 16,676 (0%) | 0% | 0 | Common Stock | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Payment of exercise price or tax liability using portion of securities received from the company at price $ 645.61 per share. | 01 Feb 2024 | 1,664 | 15,012 (0%) | 0% | 645.6 | 1,074,295 | Common Stock |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Feb 2023 | 3,702 | 3,702 | - | - | Restricted Stock Unit | |
| Eli Lilly | Ilya Yuffa | EVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 345.12 per share. | 10 Feb 2023 | 1,350 | 12,974 (0%) | 0% | 345.1 | 465,912 | Common Stock |
| Eli Lilly | Ilya Yuffa | SVP & President, LLY Intl | Sale of securities on an exchange or to another person at price $ 237.45 per share. | 15 Feb 2022 | 1,000 | 12,624 (0%) | 0% | 237.5 | 237,450 | Common Stock |
| Eli Lilly | Ilya Yuffa | SVP & President, LLY Intl | Sale of securities on an exchange or to another person at price $ 242.58 per share. | 15 Feb 2022 | 1,000 | 11,624 (0%) | 0% | 242.6 | 242,580 | Common Stock |
| Eli Lilly | Ilya Yuffa | SVP & President, LLY Intl | Grant, award, or other acquisition of securities at price $ 243.27 per share. | 09 Feb 2022 | 3,275 | 13,624 (0%) | 0% | 243.3 | 796,709 | Common Stock |
| Eli Lilly | Ilya Yuffa | SVP and Pres, Lilly Bio-Meds | Grant, award, or other acquisition of securities at price $ 205.77 per share. | 08 Feb 2021 | 3,536 | 10,349 (0%) | 0% | 205.8 | 727,603 | Common Stock |